A clinical trial to study the effectiveness of Homoeopathic Medicines in the management of Autism.
Phase 2
- Conditions
- Health Condition 1: F840- Autistic disorder
- Registration Number
- CTRI/2023/11/060280
- Lead Sponsor
- Dr Sourabh Balgonda Patil
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Children in the age group of 3 to 17 years and both sexes.
2. Participants diagnosed with Autism Spectrum Disorder as per the DSM–V.
Exclusion Criteria
1. Participants diagnosed with any organic disorders.
2. Participants with any other serious medical illness and multiple disabilities.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the efficacy of LM potencies in treating autistic disorder?
How does individualized homoeopathy compare to standard behavioral therapies for autism spectrum disorder?
Are there specific biomarkers that correlate with response to homoeopathic treatment in CTRI/2023/11/060280?
What adverse events are associated with long-term use of LM potency homoeopathic medicines in children?
What combination approaches or pharmacological agents are being explored alongside homoeopathy for autism management?